Avid Bioservices Inc (CDMO)

[biopharm]

One theory for the record....

Is there a possibility that Peregrine would find it beneficial to wait and gather as much full data trial details ( mainly and specifially MOS details !! ) as it would be beneficial in this manner:

I am not going into what happened or who was at blame/partial blame for initial "major discrepancies" which we today learned as "discrepancies" (For the record again... what happens to the stock price 9/24 if the wording "major" was left out ... hmmm )

So here goes... first read this:

http://www.bioportfolio.com/news/article/1229151/Fda-Accepting-breakthrough-Applications.html

FDA as of Nov 8, 2012 starts a new program... accepts applications where if you have a "breakthru" drug .... then we have like a monopoly game "pass immediately by your next set of trials and stop into the FDA office and collect your FDA approval!"

Now lets take a step back... you telling me that Garnick with his connections at the FDA over the many years didn't sense this was coming down the pipeline back near that dreaded day of 9/24 ? I am not saying that the company was lying about not having major discrepancies.... is it possible many drug companies get the overall stats and #'s of trials and release them before doing their final wrap up for the FDA end of phase II / beginning of phase III session with the FDA? maybe its possible that in the bio tech circle... the quicker you get into the FDA .. and out of the FDA office... and onto trials ... you can start making money.. right?

Well here we are at this period of time... 9/24 ... Is it to the benefit of Peregrine to quickly escalate into a Phase III trial design and then sit around haggling with the Partner(s) about who was going to get the best deal in up front money/back end money... regional partnerships... etc..etc..?

Is it possible that if Garnick knew about the "breakthru" application process in the works... as smart as a man Peregrine has hired.... they came to the conclusion that maybe they should "make sure" (all discrepancies) are taken care of with all of the data and maybe they should just double check the paper trail/patient trail/all vials of blood/medication or to whatever extend they are going thru to have the best damn final report available for the FDA.

Oh... and by the way... by the time this is completed they just may have hundreds of more files ready of Bavi trial data and just so happens that with all this data it just may be enough to file for that early "breakthru" designation with the FDA.

Oh... and by the way.... by the time this is completed, they now have "MUCH" more leverage in upfront money... sideways moneys... and backend money... and money wherever you look!

Oh... and by the way.... by this time, IF a partner is in the "know" it gives them a heads up to get primed and ready.

Oh... and by the way.... by this time.. it gives Peregrine management some extra time to hire some Sr. Medical Writer for FDA mamby pamby paperwork that needs to be filed and referred to the SEC.

Oh... and by the way ... does this give Peregrine just a little more time to lock in more low priced options ( not that it was planned ... but it could just work out that way )

Oh... and by the way.... if you still have a negative outlook on Peregrine Pharmaceuticals... please read all the material that all the much more knowledgable fellas have in many other posts in this thread because this is just my opinion.. my theory... and I'm sticking with it till we hit $117.

GLTA!